Haleon plc

Haleon plc Net Margin

The Net Profit Margin of Haleon plc (HLN) as of Oct 29, 2026 is 15.11 %. In the previous year, Net Profit Margin was 12.84 % — a change of 17.73% (higher).

Net Margin

15.11 %

YoY

17.73%

Last updated:

Net Profit Margin of Haleon plc is 2025 15.11 % . Net Profit Margin of Haleon plc was 2024 12.84 % . It decreases by 17.73% higher compared to the previous year.

For Haleon plc, the net margin of 15.1% is broadly stable versus 14.6% a few years ago.

The Haleon plc Net Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Net Margin
Date
Net Margin
Jan 1, 2019
7.72 USD
Jan 1, 2020
11.58 USD
Jan 1, 2021
14.56 USD
Jan 1, 2022
9.76 USD
Jan 1, 2023
9.28 USD
Jan 1, 2024
12.84 USD
Jan 1, 2025
15.11 USD
The Haleon plc Net Margin history
YEARNet MarginYoY
15.11 %+17.73%
12.84 %+38.31%
9.28 %-4.93%
9.76 %-32.96%
14.56 %+25.81%
11.58 %+49.86%
7.72 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Haleon plc Stock analysis

What does Haleon plc do? Haleon plc generates revenue through the sale of consumer healthcare products under well-known brands such as Sensodyne, Polident, Parodontax, and Biotene for oral health, and Centrum, Emergen-C, and Caltrate for vitamins and supplements. The company also sells over-the-counter products including Theraflu and Flonase for respiratory issues, Voltaren, Panadol, and Advil for pain relief, and TUMS, ENO, and Fenistil for digestive health. These products are sold across North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific regions. Haleon's portfolio targets consumers seeking solutions for oral care, respiratory ailments, pain management, and digestive wellness through established brand names. The company's revenue streams are derived from direct sales to retailers and distributors who stock these branded products in pharmacies, supermarkets, and online platforms. Haleon focuses on building strong brand recognition and loyalty among health-conscious consumers in multiple geographic markets. Its products are positioned as trusted solutions for everyday health concerns, appealing to a broad demographic across different income levels and age groups. Haleon's business model emphasizes leveraging its portfolio of acquired brands, including Sensodyne and Centrum, to maintain market leadership in key healthcare categories. By offering a diverse range of products under recognizable names, Haleon ensures consistent demand from consumers who rely on these brands for their health needs. The company's strategy centers on sustaining brand equity and expanding market presence through continuous innovation and targeted marketing efforts. Haleon plc is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Haleon plc stock

Net Profit Margin of Haleon plc is 15.11 % in 2025.

Net Profit Margin of Haleon plc changed from 12.84 % to 15.11 %, representing a 17.73% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Net Profit Margin Haleon plc since 2006 – with annual values, charts, and detailed analysis.

Net Margin measures the percentage of revenue that becomes net profit after all expenses. It is the ultimate measure of a company's profitability.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Net Profit Margin's Haleon plc with sector peers and the industry average to assess whether it is attractive.

To evaluate Net Profit Margin's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Net Profit Margin.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Margins — Haleon plc

All Key Metrics — Haleon plc